Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Traws Pharma Inc TRAW

Healthcare
Traws Pharma, Inc., formerly Onconova Therapeutics, Inc., is a virology and oncology company. The Company is engaged in developing antivirals for influenza, COVID and other respiratory infections and narazaciclib. Its proprietary portfolio includes, TRX100 (viroksavir), TRX01 (travaltrevir), and Narazaciclib. Viroksavir is a cap-dependent endonuclease inhibitor for influenza. Travaltrevir is a... see more

Recent & Breaking News (NDAQ:TRAW)

Onconova Highlights Results from Phase 2 Trial of Oral Rigosertib In Combination with Azacitidine (Vidaza®) in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting

GlobeNewswire December 3, 2018

Onconova Therapeutics Announces Business Highlights and Financial Results for Third Quarter 2018

GlobeNewswire November 13, 2018

Onconova Welcomes Richard (Ric) Woodman, M.D., as Chief Medical Officer (CMO)

GlobeNewswire November 7, 2018

Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & Exposition

GlobeNewswire November 5, 2018

Onconova Therapeutics, Inc. to Provide Corporate Update and Third Quarter 2018 Financial Results

GlobeNewswire November 1, 2018

Onconova Therapeutics to Meet with Potential Investors and Business Development Partners at the Bio-Europe 24th Annual International Partnering Conference in Copenhagen, Denmark

GlobeNewswire October 29, 2018

Onconova Therapeutics Announces Issuance of a New U.S. Patent for Rigosertib

GlobeNewswire October 17, 2018

Onconova Therapeutics to Present Update at the 2018 BIO Investor Forum in San Francisco

GlobeNewswire October 10, 2018

Onconova Therapeutics Announces Reverse Stock Split

GlobeNewswire September 25, 2018

Cancer Immunotherapy Treatment Market on the Rise as R&D Increases

PR Newswire September 21, 2018

The Growing Demand for Cancer Treatment is Raising Immunotherapy Dependence

PR Newswire August 31, 2018

Onconova Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference in New York City

GlobeNewswire August 28, 2018

Onconova Therapeutics Announces Plan for Expanding Rigosertib Clinical Trials for Patients with Myelodysplastic Syndromes (MDS) to South America with Pint Pharma

GlobeNewswire August 21, 2018

Onconova Therapeutics Reports Business Highlights and Financial Results for Second Quarter 2018

GlobeNewswire August 14, 2018

Onconova Therapeutics, Inc. to Provide Corporate Update and Second Quarter 2018 Financial Results

GlobeNewswire August 7, 2018

Onconova Therapeutics Announces Promotion for Steven M. Fruchtman, M.D.

GlobeNewswire June 21, 2018

Onconova Therapeutics Announces Presentation at the 23rd Congress of the European Hematology Association

GlobeNewswire June 7, 2018

Onconova Therapeutics, Inc. to Present at the 8th Annual LD Micro Invitational

Accesswire May 29, 2018

Onconova Therapeutics, Inc. Reports Business Highlights and Financial Results for First Quarter 2018

GlobeNewswire May 15, 2018

The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More

Benzinga.com  May 13, 2018